Pure Global

ROCHEM BIOCARE COLOMBIA S.A.S. - Authorized Company ProfileROCHEM BIOCARE COLOMBIA S.A.S.

Explore comprehensive authorized company profile for ROCHEM BIOCARE COLOMBIA S.A.S. through Pure Global AI's free Colombia medical device database. This company manufactures 789 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Dec 20, 2021 to Jun 11, 2034.

This page provides detailed insights including recent registrations, risk class distribution (I: 345, Unspecified: 166, III: 23, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
789 Devices
5 Risk Classes
ROCHEM BIOCARE COLOMBIA S.A.S.
ROCHEM BIOCARE COLOMBIA S.A.S.
Authorized Company
789
Total Devices
5
Risk Classes
2021
Earliest
2034
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

STAT-NATยฎHSV-1&2 FLEX

STAT-NATยฎHSV-1&2 FLEX

330c3e127b7cf2aa64cf6958486b2c43

III

XPERTยฎ HBV VIRAL LOAD

XPERTยฎ HBV VIRAL LOAD

42f2035ea9d996370e525375c8167df7

III

STAT-NATยฎ HSV-2

STAT-NATยฎ HSV-2

4ce7aa62a988cd12031683b0ae7f5ad7

III

STAT-NATยฎ CMV

STAT-NATยฎ CMV

2780f09271ad39af25f234a7a2e43c31

III

STAT-NATยฎ EBV

STAT-NATยฎ EBV

754996f05e0fca7adb49bb4f55317226

III

1. STAT-NATยฎ BKV

1. NATยฎ BKV STATE

aace3ace1a8bf4b9c7138c8f42bcedf3

II
Jun 11, 2034

1. SURESELECT CD GLASGOW CANCER PLUS

1. SURESELECT CD GLASGOW CANCER PLUS

35fe50dfc3d047a2f3c32d1760a98dcb

Jun 11, 2034

10. SURESELECT XT PRE-CAP

10. SURESELECT XT PRE-CAP

b7f4b9252ba65559414af433bc08fc7e

I
Jun 11, 2034

11. SURESELECT CANCER LUNG ASSAY PROBE, DNA

11. SURESELECT CANCER LUNG ASSAY PROBE, DNA

32f67f2f97750e9f0a15f9c7986e726d

I
Jun 11, 2034

12. SURESELECT CANCER COLON ASSAY PROBE, DNA

12. SURESELECT CANCER COLON ASSAY PROBE, DNA

375202e8c783744eaae3828814344add

I
Jun 11, 2034

13. SURESELECT CANCER PANCREAS ASSAY PROBE, DNA

13. SURESELECT CANCER PANCREAS ASSAY PROBE, DNA

8feac39a822f6845014bd7e737e99888

I
Jun 11, 2034

14. SURESELECT CANCER KIDNEY ASSAY PROBE, DNA

14. SURESELECT CANCER KIDNEY ASSAY PROBE, DNA

e48916e8c2ce5d4cccdcadfbd3f57647

I
Jun 11, 2034

15. SURESELECT CANCER BLADDER ASSAY PROBE, DNA

15. SURESELECT CANCER BLADDER ASSAY PROBE, DNA

33ba46ff47897a3ca0c5e52300a4ba6e

I
Jun 11, 2034

16. GENOMIC DNA REAGENTS

16. GENOMIC DNA REAGENTS

3dfb9bf7a61060df481757d740d1e176

I
Jun 11, 2034

2. SURESELECT CD GLASGOW CANCER PLUS, PC-POOL

2. SURESELECT CD GLASGOW CANCER PLUS, PC-POOL

de682d9c65015acb023b3a489bc2ebaa

I
Jun 11, 2034

3. SURESELECT XT HS HUMAN ALL EXON V8

3. SURESELECT XT HS HUMAN ALL EXON V8

8f48125d4e8e89b0e7678f8c1090021c

I
Jun 11, 2034

4. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8

4. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8

651877292fe3517b647133e664e2c54a

I
Jun 11, 2034

5. SURESELECT XT HS HUMAN ALL EXON V8+UTR

5. SURESELECT XT HS HUMAN ALL EXON V8+UTR

b0ca72921929327e11ede6c3331b0aaa

I
Jun 11, 2034

6. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8+UTR

6. SURESELECT XT HS PRE-CAP HUMAN ALL EXON V8+UTR

d9e3c7efacedc67c8b53ee62f7bfa397

I
Jun 11, 2034

7. SURESELECT XT HS HUMAN ALL EXON V8+NCV

7. SURESELECT XT HS HUMAN ALL EXON V8+NCV

4ce8d6583c81ff86490c41be1b42f27f

I
Jun 11, 2034
Risk Class Distribution
Devices by risk class
I
345
43.7% of total
II
244
30.9% of total
Unspecified
166
21.0% of total
III
23
2.9% of total
IIa
11
1.4% of total